Jonathan E. Freeman's most recent trade in Phio Pharmaceuticals Corp was a trade of 16,600 Common Stock, $.0001 par value done . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharma Corp | Jonathan E. Freeman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 16,600 | 32,655 (1%) | 0% | 0 | Common Stock, $.0001 par value | |
| Phio Pharma Corp | E. Jonathan Freeman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 14,700 | 16,055 (0%) | 0% | 0 | Common Stock, $.0001 par value | |
| Phio Pharma Corp | Jonathan E. Freeman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 1,000 | 1,000 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Phio Pharma Corp | Jonathan E. Freeman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 1,500 | 3,197 (0%) | 0% | 0 | Common stock, $0.0001 par value | |
| Phio Pharma Corp | Jonathan E. Freeman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 10,000 | 20,364 (1%) | 0% | 0 | Common stock, $0.0001 par value |